跳至主要内容
临床试验/NCT03035721
NCT03035721已完成不适用

Clinical Evaluation of a Low Protein Content Formula Fed to Full Term Healthy Infants in the First Months of Life: a Randomized Controlled Trial

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
150
试验地点
2
主要终点
Evaluate weight

研究概览

简要总结

This study aimed to evaluate the tolerance and safety of a low-protein formula in healthy full-term infants by investigating effects on growth and gastrointestinal tolerance and by identifying any adverse effects.

详细描述

Infants were randomized to receive either a standard protein formula or a low-protein formula. The composition of the low-protein formula vs the standard formula was: energy (65 vs. 68 kcal/100 mL), protein (1.2 vs. 1.7 g/100 mL).

To investigate the safety of the low-protein formula without any bias, a 4-month intervention period was selected during which the infants were fed only formula.

Anthropometric parameters (weight, length, and head circumference) and body composition were assessed at enrollment, at 2 and 4 months' of age. Parents were asked to keep a diary on the occurrence of gastrointestinal symptoms or any other symptoms and were contacted every two weeks either by clinic visits or phone calls.

The reference group was constituted by a cohort of healthy, exclusively breastfed, full-term infants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

盲法说明

Anthropometric and body composition measurements were performed by three medical investigators who were blinded to allocated treatment.

入排标准

年龄范围
1 Day 至 3 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • singleton
  • full-term infants (gestational age 37/0 to 41/6 weeks)
  • birth weight adequate for gestational age (>p10 and <p90 for gestational age) according to the World Health Organization growth charts.

排除标准

  • presence of congenital diseases
  • presence of chromosomal abnormalities
  • presence of conditions that could interfere with growth, such as brain, metabolic, cardiac and gastrointestinal diseases, perinatal infections.
  • being born to mother affected by endocrine and/or metabolic diseases
  • having a family history of allergic disease

结局指标

主要结局

Evaluate weight

时间窗: enrollment, 2 months and 4 months

Weight (g) of each baby was measured on an electronic scale accurate to 0.1 g (PEA POD Infant Body Composition System; Cosmed, Concord, CA, US). Body length was measured to the nearest 1 mm on a Harpenden neonatometer (Holtain, Crymych, UK).

Evaluate lenght

时间窗: enrollment 2 months and 4 months

Lenght (cm) of each baby was measured according standard procedures.

Evaluate head circumference

时间窗: enrollment 2 months and 4 months

Head circumference was measured to the nearest 1 mm using non-stretch measuring tape.

Evaluate gastrointestinal tolerance

时间窗: 2 months and 4 months

Parents were asked to keep a diary on the occurrence of gastrointestinal symptoms or any other symptoms and were contacted every two weeks either by clinic visits or phone calls. The occurrence of spitting up, vomiting and colic, defined as intermittent attacks of abdominal pain when the baby screamed and drew up his/her legs but was well between episodes, was recorded. Colic was further classified as severe if the episodes were more than twice per day. Daily frequency of stool passage was also collected.

Evaluate occurence of adverse events

时间窗: 2 months and 4 months

Adverse events were assessed based on inquires to the parents and on their daily records.

Evaluate body composition (fat mass and fat free mass)

时间窗: enrollment, 2 months and 4 months

Body composition \[fat mass and fat free mass (g)\]was assessed using an air-displacement plethysmography (PEA POD Infant Body Composition System; COSMED, Italy).

Evaluate weight increase

时间窗: 2 months, 4 months

Weight increase (g/day) was calculated as a change in body weight from weight at study enrollment divided by the time interval from enrolment to the assessment at 4 months Fat mass (g/day) and fat free mass (g/day) increases were also calculated.

次要结局

  • Evaluate body mass index (k/m2: weight/length2)(enrollment, 2 months and 4 months)
  • Evaluate z-score(enrollment, 2 months and 4 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Clinical Evaluation of a Low Protein Content Formula... | 临床试验